PPARA and breast cancer: Chandran et al. showed that clofibrate treatment activated the PPARα transcriptional activity and exerted an anti-proliferative effect on breast cancer cells by regulating the levels of tumor suppressors, cell cycle inhibitors, and cell to cycle checkpoint kinases, causing cells to arrest in the G0/G1 phase and significantly inhibiting cell growth.